Hong Kong Stock Market Anomaly | Kangtuo Pharmaceuticals-B (09939.HK) rose more than 7% in intra-day trading. The phase II clinical trial of a drug for treating male pattern baldness in China has reached its main endpoint.

According to the Zhitong Finance and Economics App, Kangtuo Pharmaceutical -B (09939.HK) surged over 7% in the midday trading, up 1.19% as of the time of publication, trading at 2.56 Hong Kong dollars, with a turnover of 13.85 million Hong Kong dollars.